For the protection of our patients and staff, Pacific Neuroscience Institute has initiated temporary measures to help reduce the spread of COVID-19

Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas

Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas

Date: July 30, 2014
Type:
Size:

John Wayne Cancer Institute